Literature DB >> 20043054

Hidradenitis suppurativa: a disease with male predominance in Tunisia.

Amel Mebazaa1, Rym Ben Hadid, R Cheikh Rouhou, Sondes Trojjet, Dalenda El Euch, Mourad Mokni, Moncef Zitouna, Amel Ben Osman.   

Abstract

BACKGROUND: hidradenitis suppurativa (HS) is a chronic inflammatory, suppurating, fistulizing, and scar-producing disease of apocrine gland-bearing skin. The diagnosis is primarily clinical, based on the presence of both sinus tracts and abscesses with a characteristic distribution.
OBJECTIVE: Review of epidemiological, clinical, and prognostic characteristics of HS and discussion of the etiopathogenic aspects of this chronic problem. PATIENTS AND METHODS: We retrospectively report all cases of HS followed at the Department of Dermatology between January 1985 and December 2008.
RESULTS: Eleven patients (10 male and 1 female), with a mean age of 35.2 years (range 21 dash, vertical53 years) at HS diagnosis were followed for HS. The average age of disease onset was 23.9 years. The median delay between onset of symptoms and diagnosis was 144 months (range 1 dash, vertical408 months). Clinical features showed inflamed discharging papules or nodules, painful tender erythematous nodules, and double-ended comedones. The disease mainly affected the axillary, anal, perineal, and genital areas. Histologically, dermal features showed active folliculitis or abscess, sinus tract formation, fibrosis, and granuloma formation. Pathological associations (Darier's disease and Down syndrome) were noted in two patients. Treatment consisted of antibiotics in eight patients, retinoids (1 mg/kg/ day) in three patients, and surgery in three patients. The mean follow-up was 13 months (range 2 dash, vertical30 months). Recurrence of lesions was observed in all patients approximately 1 month after treatment withdrawal. The Down syndrome patient developed vaginal hydrocele of the testis as a complication of his staphylococcic ulcers. In all cases healing occurred with substantial scarring. DISCUSSION: An obvious male predominance was noted in our patients as well as a delay in the diagnosis of HS, which could be explained by non-recognition of the disease by non-specialists that see the patients at the primary-care level.

Entities:  

Mesh:

Year:  2009        PMID: 20043054

Source DB:  PubMed          Journal:  Acta Dermatovenerol Alp Pannonica Adriat        ISSN: 1318-4458


  9 in total

1.  The Burden of Hidradenitis Suppurativa in a Cohort of Patients in Southern Finland: A Pilot Study.

Authors:  Nicolas Kluger; Martta Ranta; Martina Serlachius
Journal:  Skin Appendage Disord       Date:  2017-01-12

Review 2.  What is hidradenitis suppurativa?

Authors:  Erika Yue Lee; Raed Alhusayen; Perla Lansang; Neil Shear; Jensen Yeung
Journal:  Can Fam Physician       Date:  2017-02       Impact factor: 3.275

3.  Hidradenitis Suppurativa International Online Community: Patient Characteristics and a Novel Model of Treatment Effectiveness.

Authors:  Jen Barak-Levitt; Ron Held; Yossi Synett; Noa Kremer; Emmilia Hodak; Shany Sherman
Journal:  Acta Derm Venereol       Date:  2022-04-04       Impact factor: 3.875

4.  The effect of smoking and age on the response to first-line therapy of hidradenitis suppurativa: An institutional retrospective cohort study.

Authors:  George Denny; Milan J Anadkat
Journal:  J Am Acad Dermatol       Date:  2016-09-28       Impact factor: 11.527

Review 5. 

Authors:  Erika Yue Lee; Raed Alhusayen; Perla Lansang; Neil Shear; Jensen Yeung
Journal:  Can Fam Physician       Date:  2017-02       Impact factor: 3.275

6.  Hidradenitis Suppurativa: Estimated Prevalence, Clinical Features, and Risk Factors in Riyadh, Saudi Arabia.

Authors:  Haifa Alsadhan; Abdulrahman I Alfawzan; Amirah Yaqoub; Alyah Almoneef; Mohammad Almohideb
Journal:  Cureus       Date:  2022-03-10

7.  Radiation therapy in chronic hidradenitis suppurativa: case report.

Authors:  Pitchaya Sakyanun; Thirada Vongvanichvathana; Prasert Lertsanguansinchai
Journal:  Radiat Oncol J       Date:  2022-03-03

8.  Hidradenitis Suppurativa in Kuala Lumpur, Malaysia: A 7-Year Retrospective Review.

Authors:  Moonyza Akmal Ahmad Kamil; Azura Mohd Affandi
Journal:  Dermatol Res Pract       Date:  2018-05-22

9.  The Comorbidity Burden of Hidradenitis Suppurativa in the United States: A Claims Data Analysis.

Authors:  Alexandra B Kimball; Murali Sundaram; Genevieve Gauthier; Annie Guérin; Irina Pivneva; Rakesh Singh; Arijit Ganguli
Journal:  Dermatol Ther (Heidelb)       Date:  2018-10-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.